electroCore to Announce Second Quarter June 30, 2026, Financial Results on Thursday, August 6, 2026

Rhea-AI Summary

electroCore (Nasdaq: ECOR) will report financial results for the second quarter ended June 30, 2026, after the market close on Thursday, August 6, 2026. Management will host a results webinar at 4:30 PM EDT, with investor access via phone dial-in, webinar ID, passcode, and an online registration link.

Market reaction after 2Q26 earnings report: ECOR +7.00%

+7.00% $6.50

15m delay

+7.00% Vs previous close

$6.50 Last Price

$6.09 $6.83 Day Range

$54.06M Market Cap

0.1x Rel. Volume

Following this news, ECOR has gained 7.00%, reflecting a notable positive market reaction. Our momentum scanner has triggered 3 alerts so far, indicating moderate trading interest and price volatility. The stock is currently trading at $6.50.

Data tracked by StockTitan Argus (15 min delayed). Upgrade to Gold for real-time data.

Market Context

Insider data showed Net Buying, with 9,992 shares purchased versus 9,667 sold. That adds a mixed own...

Analysis

Insider data showed Net Buying, with 9,992 shares purchased versus 9,667 sold. That adds a mixed ownership signal to the scheduled results notice; the resale registration and upcoming figures remain key items to monitor.

Key Figures

Quarter End: June 30, 2026 Results Date: August 6, 2026 Webinar Time: 4:30 PM EDT

3 metrics

Quarter End June 30, 2026 Second quarter financial results

Results Date August 6, 2026 After market close

Webinar Time 4:30 PM EDT Management review of financial results

Previous Earnings date Reports

2 past events · Latest: Apr 29 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
Apr 29	Earnings date	Neutral	+0.0%	Announced first-quarter results date and management webinar details
Mar 09	Earnings date	Neutral	-3.1%	Announced fourth-quarter and full-year results date and webinar

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The two prior earnings-date announcements produced reactions of 0% and -3.07%, with an average move of -1.53%.

Key Terms

bioelectronic medicine

1 terms

bioelectronic medicine medical

"a commercial-stage bioelectronic medicine and wellness company"

Bioelectronic medicine uses small implanted or wearable devices to change the body’s electrical or nerve signals to prevent or treat illness instead of relying only on drugs. Think of it like a pacemaker for different organs: it can turn problematic signals up or down to relieve symptoms. For investors it matters because successful devices can open new treatment markets, offer recurring revenue from device sales and follow‑up care, and carry clear clinical and regulatory risks that affect value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ROCKAWAY, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the second quarter ended June 30, 2026, after the close of the market on Thursday, August 6, 2026.

Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:

Thursday, August 6, 4:30 PM EDT
Dial-In: (646) 931-3860
Webinar ID: 849 0856 5421
Passcode: 305949
Registration Link: Click here to participate and ask questions on the call.

About electroCore, Inc.
electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

Contact:
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com

FAQ

When will electroCore (ECOR) report its Q2 2026 financial results?

electroCore will report Q2 2026 financial results on Thursday, August 6, 2026, after the market close. According to electroCore, the announcement covers the quarter ended June 30, 2026, and will be followed by a management webinar to discuss the results.

What time is electroCore’s Q2 2026 earnings webinar on August 6, 2026?

electroCore’s Q2 2026 earnings webinar starts at 4:30 PM EDT on August 6, 2026. According to electroCore, management will review the financial results and answer investor questions during this scheduled online session following the market close.

How can investors access the electroCore (ECOR) Q2 2026 earnings call?

Investors can access the electroCore Q2 2026 earnings call via webinar and phone dial-in at (646) 931-3860. According to electroCore, participants use Webinar ID 849 0856 5421 and Passcode 305949, with an online registration link available for asking questions.

What is the dial-in number and passcode for electroCore’s Q2 2026 earnings webinar?

The dial-in number is (646) 931-3860 and the passcode is 305949. According to electroCore, investors should also use Webinar ID 849 0856 5421 and may register through the provided online link to participate and submit questions.

Will electroCore management take questions on the Q2 2026 earnings call?

Yes, management plans to answer questions during the Q2 2026 earnings webinar. According to electroCore, investors can use the registration link to participate and submit questions, following the company’s review of financial results at 4:30 PM EDT on August 6, 2026.